Learning Objectives
Upon completion of this activity, participants should be able to:
Describe advantages and disadvantages of current treatment choices for HBeAg-negative chronic hepatitis B patients
Outline management of HBeAg-negative chronic hepatitis B patients on antiviral treatment
Review guidelines for initiating treatment in individuals with HBeAg-negative chronic hepatitis B
Explore options and receive feedback on your choices of therapy for a challenging patient with advanced liver disease.